SBIR/STTR Research Award

POLYMER AMPLIFIED NUCLEIC ACID DETECTION

Award identifier ce5d58ca9afb8cbcef5a107586b54a8d79b2bc0707efaddc025ba85c61f057b3Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$279,077

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Nomadics, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
EK87N63LP4Y4
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Realizing important advances in the screening, diagnosis and treatment of cancer depends in large part on the sensitivity, simplicity and cost of detecting specific nucleic acid sequences. Nomadics proposes to adapt amplifying fluorescent polymer (AFP) technology to nucleic acid detection. AFPs are an innovative and important new class of polymers that amplify optical signatures resulting from fluorescence resonance energy transfer (FRET) or fluorescence quenching events. Combining this inherent signal amplification with the unique specificity exhibited by nucleic acid hybridization events will enable a new generation of solid-state, nucleic acid sensors that do not rely on target amplification or catalyzed reporter deposition. The specific aims of the proposed effort are to: 1) optimize transduction (FRET or quenching) between nucleic acid functionalized AFP films and target nucleic acid sequences via hybridization, 2) quantify the sensitivity and selectivity of AFP-based systems, and 3) fabricate and evaluate various prototype devices/formats. Overall, the goal is to establish the utility of AFP technology towards the detection of nucleic acid sequences and lay the groundwork for a Phase II program aimed at exploiting amplification in novel detection formats. PROPOSED COMMERCIAL APPLICATION: Nucleic acid detection plays a pivotal role in biological research, drug development and, increasingly, diagnosis. By offering improvements in sensitivity, amplifying fluorescent polymer (AFP) technology will enable the development of simple, rapid low-cost nucleic acid detection systems. These will find immediate use in the laboratory (i.e., microarray platforms, gene expression analysis, etc.) with the ultimate goal being the development of molecular diagnostic devices.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

92 SBIR/STTR records share this UEI (1995–2007). Reported award amounts total $25,070,260. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, National Science Foundation, Department of Health and Human Services, Department of Energy, Department of Homeland Security, Department of Commerce

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.